Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$84.23 - $147.57 $24,763 - $43,385
-294 Reduced 11.75%
2,208 $209,000
Q1 2022

May 12, 2022

SELL
$122.89 - $171.74 $3,318 - $4,636
-27 Reduced 1.07%
2,502 $346,000
Q4 2021

Feb 02, 2022

SELL
$156.0 - $265.78 $2,496 - $4,252
-16 Reduced 0.63%
2,529 $462,000
Q3 2021

Nov 12, 2021

BUY
$228.69 - $274.2 $7,318 - $8,774
32 Added 1.27%
2,545 $658,000
Q2 2021

Aug 03, 2021

SELL
$169.89 - $231.37 $24,634 - $33,548
-145 Reduced 5.46%
2,513 $577,000
Q1 2021

May 17, 2021

SELL
$143.93 - $207.3 $33,391 - $48,093
-232 Reduced 8.03%
2,658 $448,000
Q4 2020

Feb 11, 2021

BUY
$96.1 - $151.18 $4,036 - $6,349
42 Added 1.47%
2,890 $421,000
Q3 2020

Nov 13, 2020

SELL
$90.16 - $107.61 $12,442 - $14,850
-138 Reduced 4.62%
2,848 $281,000
Q2 2020

Aug 11, 2020

BUY
$52.17 - $95.63 $3,234 - $5,929
62 Added 2.12%
2,986 $278,000
Q1 2020

May 08, 2020

SELL
$52.76 - $109.0 $19,362 - $40,003
-367 Reduced 11.15%
2,924 $162,000
Q4 2019

Feb 07, 2020

SELL
$69.39 - $97.59 $19,429 - $27,325
-280 Reduced 7.84%
3,291 $316,000
Q3 2019

Oct 31, 2019

SELL
$64.17 - $84.08 $13,475 - $17,656
-210 Reduced 5.55%
3,571 $254,000
Q2 2019

Aug 09, 2019

SELL
$70.1 - $85.17 $3,434 - $4,173
-49 Reduced 1.28%
3,781 $322,000
Q1 2019

Apr 24, 2019

SELL
$77.0 - $99.34 $19,250 - $24,835
-250 Reduced 6.13%
3,830 $326,000
Q4 2018

Jan 30, 2019

SELL
$83.85 - $110.34 $4,024 - $5,296
-48 Reduced 1.16%
4,080 $351,000
Q3 2018

Oct 26, 2018

SELL
$97.14 - $113.31 $91,603 - $106,851
-943 Reduced 18.6%
4,128 $468,000
Q2 2018

Aug 10, 2018

SELL
$74.5 - $108.91 $14,825 - $21,673
-199 Reduced 3.78%
5,071 $527,000
Q1 2018

May 09, 2018

BUY
$58.36 - $83.18 $50,364 - $71,784
863 Added 19.58%
5,270 $416,000
Q3 2017

Nov 14, 2017

BUY
$84.87 - $109.54 $374,022 - $482,742
4,407
4,407 $387,000

Others Institutions Holding HSKA

About HESKA CORP


  • Ticker HSKA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 10,818,900
  • Description
  • Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...
More about HSKA
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.